PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsStemline Therapeutics
Stemline Therapeutics(STML)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ElzonrisTagraxofusp2018-12-21
Lymphoma
,
Malignant histiocytic disorders
NexpovioSelinexor2021-03-262032-2035
Multiple myeloma
OrserduElacestrant2023-01-272024-2038
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
TAGRAXOFUSP
biphenotypic leukemia acute
,
t-cell lymphoma
,
hodgkin disease
,
b-cell lymphoma
,
myeloid leukemia acute
,
blastic plasmacytoid dendritic cell neoplasm
,
leukemia
,
myeloid leukemia
,
myelodysplastic syndromes
,
primary myelofibrosis
,
myelomonocytic leukemia chronic
,
precursor cell lymphoblastic leukemia-lymphoma
,
neoplasms
,
residual neoplasm
,
hematologic neoplasms
,
multiple myeloma
,
plasma cell neoplasms
,
myelomonocytic leukemia acute
,
myelomonocytic leukemia juvenile
,
recurrence
,
myeloproliferative disorders
,
preleukemia
,
syndrome
,
burkitt lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
myelodysplastic-myeloproliferative diseases
,
pathologic complete response
Elacestrant
liver diseases
,
hepatic insufficiency
,
hot flashes
,
neoplasms
,
endometrial neoplasms
,
brain neoplasms
,
central nervous system neoplasms
,
central nervous system diseases
,
brain diseases
,
neoplasms by site
,
breast diseases
,
intraductal carcinoma noninfiltrating
,
neoplasm metastasis
,
hereditary breast and ovarian cancer syndrome
,
radiotherapy
,
recurrence
,
leiomyosarcoma
,
perivascular epithelioid cell neoplasms
,
endometrial stromal sarcoma
,
breast neoplasms
,
triple negative breast neoplasms
,
male breast neoplasms
,
ventricular tachycardia
,
tachycardia
,
healthy volunteers/patients
Regramostim
glioblastoma
Carboxymethylcellulose
glioblastoma
FELEZONEXOR
neoplasms
Endocrine
healthy volunteers/patients
,
ovarian neoplasms
,
triple negative breast neoplasms
,
non-small-cell lung carcinoma
,
castration-resistant prostatic neoplasms
,
liposarcoma
,
colorectal neoplasms
,
lobular carcinoma
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
neoplasms
,
type 2 diabetes mellitus
,
prostatic neoplasms
,
endocrine system diseases
,
diabetes mellitus
,
male breast neoplasms
,
recurrence
,
unilateral breast neoplasms
,
obesity
,
glucose metabolism disorders
,
metabolic diseases
,
body weight
,
overweight
,
nutrition disorders
,
signs and symptoms
,
nutritional and metabolic diseases
,
signs and symptoms pathological conditions
,
overnutrition
,
neoplasm metastasis
,
breast neoplasms
,
acromegaly
,
laron syndrome
,
pituitary dwarfism
,
left ventricular hypertrophy
,
left ventricular dysfunction
,
bipolar disorder
,
coronary disease
,
coronary artery disease
,
chronic disease
,
traumatic brain injuries
,
brain concussion
,
hypopituitarism
Hiltonol
castration-resistant prostatic neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use